Beta cell primary cilia mediate somatostatin responsiveness via SSTR3.

Samantha E Adamson, Zipeng A Li, Jing W Hughes
Author Information
  1. Samantha E Adamson: Department of Medicine, Division of Endocrinology, Metabolism & Lipid Research, Washington University School of Medicine, St. Louis, USA. ORCID
  2. Zipeng A Li: Department of Medicine, Division of Endocrinology, Metabolism & Lipid Research, Washington University School of Medicine, St. Louis, USA. ORCID
  3. Jing W Hughes: Department of Medicine, Division of Endocrinology, Metabolism & Lipid Research, Washington University School of Medicine, St. Louis, USA. ORCID

Abstract

Somatostatin is a paracrine modulator of insulin secretion and beta cell function with pleotropic effects on glucose homeostasis. The mechanism of somatostatin-mediated communication between delta and beta cells is not well-understood, which we address in this study via the ciliary somatostatin receptor 3 (SSTR3). Primary cilia are membrane organelles that act as signaling hubs in islets by virtue of their subcellular location and enrichment in signaling proteins such as G-protein coupled receptors (GPCRs). We show that SSTR3, a ciliary GPCR, mediates somatostatin suppression of insulin secretion in mouse islets. Quantitative analysis of calcium flux using a mouse model of genetically encoded beta cell-specific GCaMP6f calcium reporter shows that somatostatin signaling alters beta cell calcium flux after physiologic glucose stimulation, an effect that depends on endogenous SSTR3 expression and the presence of intact primary cilia on beta cells. Comparative studies using SSTR isoform antagonists demonstrate a role for SSTR3 in mediating somatostatin regulation of insulin secretion in mouse islets. Our findings support a model in which ciliary SSTR3 mediates a distinct pathway of delta-to-beta cell regulatory crosstalk and may serve as a target for paracrine modulation.

Keywords

References

  1. Diabetologia. 1977 Sep;13(5):537-44 [PMID: 908478]
  2. Nature. 2013 Jul 18;499(7458):295-300 [PMID: 23868258]
  3. Horm Metab Res. 1985 Oct;17(10):510-1 [PMID: 2866155]
  4. Front Endocrinol (Lausanne). 2021 Mar 10;12:633944 [PMID: 33776927]
  5. Proc Natl Acad Sci U S A. 2020 Apr 21;117(16):8912-8923 [PMID: 32253320]
  6. J Endocrinol Invest. 1989 Jun;12(6):413-7 [PMID: 2671112]
  7. ACS Med Chem Lett. 2012 May 07;3(6):484-9 [PMID: 24900499]
  8. ACS Med Chem Lett. 2015 Mar 18;6(5):513-7 [PMID: 26005524]
  9. Mol Biol Cell. 2008 Apr;19(4):1540-7 [PMID: 18256283]
  10. Am J Physiol. 1990 Dec;259(6 Pt 1):C854-61 [PMID: 1979715]
  11. Diabetes. 2019 Jul;68(7):1394-1402 [PMID: 31127054]
  12. Drug Deliv Transl Res. 2022 Apr;12(4):792-804 [PMID: 33683625]
  13. Nat Commun. 2014 Nov 06;5:5308 [PMID: 25374274]
  14. Curr Opin Nephrol Hypertens. 2016 Sep;25(5):452-8 [PMID: 27341444]
  15. J Biol Chem. 1996 Feb 16;271(7):3647-51 [PMID: 8631975]
  16. Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13069-13074 [PMID: 27799542]
  17. Diabetes. 1967 Jan;16(1):35-9 [PMID: 5333500]
  18. J Cell Biol. 2023 Jan 2;222(1): [PMID: 36350286]
  19. Sensors (Basel). 2015 Oct 28;15(11):27393-419 [PMID: 26516866]
  20. Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16009-12 [PMID: 20798346]
  21. Diabetes Metab J. 2023 Jul;47(4):454-469 [PMID: 37105527]
  22. J Physiol. 1991 Sep;441:615-37 [PMID: 1687749]
  23. J Endocrinol Invest. 1998 Jul-Aug;21(7):454-8 [PMID: 9766261]
  24. Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):12066-12071 [PMID: 31142652]
  25. Cilia. 2013 Jul 03;2(1):8 [PMID: 23819925]
  26. Am J Physiol Endocrinol Metab. 2023 Jan 1;324(1):E42-E55 [PMID: 36449570]
  27. Diabetes. 2013 Aug;62(8):2968-77 [PMID: 23630299]
  28. Genes Dev. 2021 Sep 1;35(17-18):1243-1255 [PMID: 34385262]
  29. Diabetes. 1999 Jan;48(1):77-85 [PMID: 9892225]
  30. Ann N Y Acad Sci. 1998 Nov 17;859:208-9 [PMID: 9928389]
  31. J Clin Invest. 1974 Dec;54(6):1395-402 [PMID: 4436439]
  32. Compr Physiol. 2021 Jun 30;11(3):2191-2225 [PMID: 34190340]
  33. Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1863-70 [PMID: 17327372]
  34. Biochim Biophys Acta. 2014 Sep;1842(9):1518-26 [PMID: 24925129]
  35. J Endocrinol Invest. 1988 Jul-Aug;11(7):501-7 [PMID: 3049768]
  36. Diabetes Obes Metab. 2022 Sep;24(9):1741-1752 [PMID: 35546791]
  37. Sci Adv. 2022 Sep 23;8(38):eabq8486 [PMID: 36149960]
  38. Biomed Res. 2011 Feb;32(1):73-81 [PMID: 21383513]
  39. Elife. 2020 Nov 09;9: [PMID: 33164752]
  40. Elife. 2018 Feb 14;7: [PMID: 29443690]
  41. Front Cell Dev Biol. 2022 Dec 01;10:1082193 [PMID: 36531945]
  42. Cell Calcium. 2019 Nov;83:102081 [PMID: 31563790]
  43. Curr Opin Cell Biol. 2016 Apr;39:84-92 [PMID: 26926036]
  44. Diabetes Obes Metab. 2022 May;24(5):908-917 [PMID: 35060297]
  45. J Neurophysiol. 2009 Sep;102(3):1801-10 [PMID: 19605612]
  46. J Histochem Cytochem. 2004 Mar;52(3):391-400 [PMID: 14966206]
  47. Front Endocrinol (Lausanne). 2022 Jun 23;13:922983 [PMID: 35813631]
  48. Diabetes. 2008 Jun;57(6):1618-28 [PMID: 18390794]
  49. Diabetes. 2006 Apr;55(4):1029-33 [PMID: 16567525]
  50. Pituitary. 2016 Oct;19(5):536-43 [PMID: 27405306]
  51. Diabetes. 2017 Apr;66(4):960-969 [PMID: 28130310]
  52. Cells. 2021 Aug 06;10(8): [PMID: 34440773]
  53. Nat Commun. 2022 Oct 29;13(1):6461 [PMID: 36309517]
  54. J Physiol. 2011 Nov 15;589(Pt 22):5453-66 [PMID: 21930600]
  55. Metabolites. 2020 Dec 18;10(12): [PMID: 33353164]
  56. Pancreas. 2010 Aug;39(6):836-42 [PMID: 20182388]
  57. Diabetes. 2009 Feb;58(2):403-11 [PMID: 18984743]
  58. Mol Cell Endocrinol. 2009 Jan 15;297(1-2):58-72 [PMID: 18706473]
  59. Channels (Austin). 2014;8(6):519-27 [PMID: 25483286]
  60. N Engl J Med. 1975 May 8;292(19):985-9 [PMID: 804137]
  61. Am J Physiol Endocrinol Metab. 2012 Nov 1;303(9):E1107-16 [PMID: 22932785]

Grants

  1. R03 DK127748/NIDDK NIH HHS
  2. K08 DK115795/NIDDK NIH HHS
  3. K12 DK133995/NIDDK NIH HHS
  4. T32 DK007120/NIDDK NIH HHS
  5. IK2 CX002027/CSRD VA

MeSH Term

Cilia
Glucose
Receptors, Somatostatin
Somatostatin
Animals
Mice

Chemicals

Glucose
Receptors, Somatostatin
Somatostatin
somatostatin receptor 3

Word Cloud

Created with Highcharts 10.0.0SSTR3betasomatostatincellciliacalciuminsulinsecretionciliarysignalingisletsmouseprimaryparacrineglucosecellsviamediatesfluxusingmodelSomatostatinmodulatorfunctionpleotropiceffectshomeostasismechanismsomatostatin-mediatedcommunicationdeltawell-understoodaddressstudyreceptor3PrimarymembraneorganellesacthubsvirtuesubcellularlocationenrichmentproteinsG-proteincoupledreceptorsGPCRsshowGPCRsuppressionQuantitativeanalysisgeneticallyencodedcell-specificGCaMP6freportershowsaltersphysiologicstimulationeffectdependsendogenousexpressionpresenceintactComparativestudiesSSTRisoformantagonistsdemonstraterolemediatingregulationfindingssupportdistinctpathwaydelta-to-betaregulatorycrosstalkmayservetargetmodulationBetamediateresponsivenessislet

Similar Articles

Cited By